Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about NASDAQ:IMUX Recent news which mentions NASDAQ:IMUX Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day May 30, 2024 Tags NASDAQ:IMUX From News Direct Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 May 08, 2024 Tickers IMUX Tags Earnings Reports Market News NASDAQ:IMUX From InvestorPlace Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role April 29, 2024 Tags NASDAQ:IMUX From News Direct Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic secures key patent, boosting MS drug exclusivity and global IP strategy March 21, 2024 Tags NASDAQ:IMUX From News Direct Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024 March 08, 2024 Tags NASDAQ:IMUX From News Direct Immunic reports successful 2023 and prepares for key 2025 milestones February 22, 2024 Tags NASDAQ:IMUX From News Direct Immunic focusing on business development during Q4 November 14, 2023 Tags NASDAQ:IMUX From News Direct Immunic CSO hails "great" progress with MS program October 24, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic "super excited" about latest PMS trial data October 11, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment August 21, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO says Q2 results "couldn't be better" August 07, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic Inc eyeing "big step" for multiple sclerosis patients July 25, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases June 26, 2023 Tags NASDAQ:IMUX From News Direct Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis May 31, 2023 Tags NASDAQ:IMUX From News Direct Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program May 17, 2023 Tags NASDAQ:IMUX From News Direct Immunic Inc set to bring relief with encouraging results May 16, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic IMU-856 trial data "clearly goes beyond" initial expectations May 04, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic gets a "positive surprise" from lead asset trial April 13, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct 2 Biotech Stocks to Take off Your Watchlist in 2022 October 19, 2022 Tags NASDAQ:IMUX :DNA From StockNews.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.